U.S. Physical Therapy Reports Record Visits, 2025 Adj. EBITDA Hits $95M; 2026 Guidance $102M-$106M
summarizeSummary
U.S. Physical Therapy, Inc. announced strong financial results, reporting record visitation and a 16.1% increase in full-year 2025 adjusted EBITDA to $95.0 million. The company also provided optimistic guidance for 2026, projecting adjusted EBITDA to be between $102 million and $106 million. This positive update, stemming from a new 8-K filing on March 3rd, provides specific, actionable financial figures that were not detailed in the previous general disclosures of strong operational results from late February. The robust performance and favorable outlook are likely to be viewed positively by investors, indicating continued growth in its physical therapy and injury prevention segments. Traders will monitor future reports for sustained growth and any revisions to the 2026 guidance.
At the time of this announcement, USPH was trading at $82.50 on NYSE in the Trade & Services sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $62.77 to $93.50. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.